Christian Mueller
Corporate Officer/Principal bij IMMUTEP LIMITED
Profiel
Christian Mueller is currently working as the SVP-Regulatory & Strategy at Immutep Ltd.
Previously, he worked as a Project Manager at Medical Enzymes AG.
He graduated from the Technical University of Berlin.
Actieve functies van Christian Mueller
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUTEP LIMITED | Corporate Officer/Principal | - |
Eerdere bekende functies van Christian Mueller
| Bedrijven | Functie | Einde |
|---|---|---|
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Opleiding van Christian Mueller
| Technical University of Berlin | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
